Sign in

CIK 0001743881

  • Large accelerated filer

BridgeBio Pharma, Inc.

Sign in to watch
Ticker
BBIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 650-391-9740
Business address
3160 PORTER DR., SUITE 250, PALO ALTO, CA, 94304
Former names
BridgeBio Pharma LLC
  1. 4 Grant or award Director acquired 3,990 shares (grant or award)
  2. 4 Grant or award Director acquired 3,990 shares (grant or award)
  3. 4 Grant or award Director acquired 3,990 shares (grant or award)
  4. 4 Grant or award Director acquired 3,990 shares (grant or award)
  5. 4 Grant or award Director acquired 3,990 shares (grant or award)
  6. 4 Shares withheld for taxes Director gave up 788 shares (to pay taxes)
  7. 4 Planned sale Director sold 90,240 shares at an average $66.62 ($6,012,157)
  8. 4 Planned sale Chief Executive Officer sold 80,000 shares at an average $67.67 ($5,413,289)
  9. 4 Planned sale Chief Executive Officer sold 26,103 shares at an average $69.44 ($1,812,522)
  10. 4 Planned sale President and CFO sold 13,651 shares at an average $65.08 ($888,419)
  11. 4 Shares withheld for taxes Chief Executive Officer gave up 36,236 shares (to pay taxes)
  12. 4 Shares withheld for taxes Chief Accounting Officer gave up 4,714 shares (to pay taxes)
  13. 4 Planned sale Director sold 10,000 shares at an average $67.15 ($671,456)
  14. 4 Planned sale Chief Executive Officer sold 80,000 shares at an average $67.40 ($5,392,243)
  15. 4 Planned sale Chief Accounting Officer sold 2,000 shares at $71.58 ($143,160)
  16. 4 Planned sale Chief Executive Officer sold 80,000 shares at an average $74.61 ($5,968,780)
  17. 4 Grant or award President and CFO acquired 59,041 shares (grant or award)
  18. 4 Grant or award Chief Accounting Officer acquired 14,170 shares (grant or award)
  19. 4 Derivatives Options or other derivatives
  20. 4 Planned sale Chief Executive Officer sold 80,000 shares at an average $68.76 ($5,501,068)

Page 2 of 23 · 453 filings